メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
竹中 政史
医学部・腎泌尿器外科学
h-index
329
被引用数
10
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2012
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(38)
類似のプロファイル
(6)
フィンガープリント
Masashi Takenakaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Robot-Assisted Prostatectomy
100%
Cystectomy
96%
Partial Nephrectomy
77%
Retrospective Study
59%
Continence
48%
Recurrent Disease
46%
Prostate Cancer
44%
Neoadjuvant Chemotherapy
38%
Retroperitoneal Lymph Node Dissection
38%
Respiratory Disease
38%
Overall Survival
36%
Bleeding
36%
Cancer Specific Survival
30%
Neoplasm
27%
Interleukin 17
27%
Bladder Cancer
25%
Lung Graft Rejection
24%
Major Histocompatibility Complex
24%
Sacrocolpopexy
23%
Recurrence Free Survival
23%
Da Vinci Surgical System
22%
Urinary System
22%
Urinary Diversion
21%
Postoperative Ileus
21%
Operation Duration
20%
Glomerular Filtration Rate
20%
Legionella
19%
Long Term Survival
19%
Tumor Necrosis Factor
19%
Heart Muscle Ischemia
19%
Ileal Conduit
19%
Brachytherapy
19%
Heart Death
19%
Immunopathogenesis
19%
Inferior Vena Cava
19%
Graft Failure
19%
Transitional Cell Carcinoma
19%
Complement Activation
19%
Renin Angiotensin Aldosterone System
19%
Angiotensin Receptor Antagonist
19%
Muscle Invasive Bladder Cancer
19%
Thrombectomy
19%
ACE Inhibitor
19%
Computer Assisted Tomography
19%
Bronchiolitis Obliterans
19%
Radical Nephrectomy
19%
Kidney Tumour
19%
Propensity Score Matching
18%
Urine Incontinence
17%
Tubulin
16%
Immunology and Microbiology
Monospecific Antibody
94%
Major Histocompatibility Complex
58%
Immunopathogenesis
58%
Autoimmunity
42%
Interleukin 17
36%
Immune Response
35%
Macrophage
33%
T-Helper Cell
32%
MHC Class I
30%
B Cell
27%
Lung Graft Rejection
24%
Wild Type
23%
Mouse
22%
Chronic Graft Rejection
22%
Bronchiolitis
19%
Digestive System
19%
Gene Expression Profiling
19%
Immunotherapy
19%
Overall Survival
19%
Carcinoma Cell
19%
MHC Class II
19%
Cytotoxic T-Cell
19%
Tumor Cell
19%
Regulatory T Cell
19%
Transplant Procedure
19%
Complement Activation
19%
Lung Transplantation
16%
Indoleamine 2,3-dioxygenase
16%
Gene Expression
14%
Cancer Specific Survival
14%
CD8
11%
Neutrophil Granulocyte
10%
interferon
10%
Wild Type Mouse
10%
CD4
10%
Growth Factor
10%
Population
9%
Knockout Mouse
9%
Recurrence Free Survival
9%
Biochemical Recurrence Free Survival
9%
Screening Test
9%
T Cell Subset
7%
Interleukin 10
7%
Cytokine
7%
Enzyme-Linked Immunosorbent Assay
7%
Enzyme-Linked Immunospot Assay
7%
Th17 Cell
6%
Mediator
6%
Complement Component C1q
6%
Neutrophil Chemotaxis
5%
Keyphrases
Robot-assisted Radical Prostatectomy
38%
Pentafecta Outcomes
38%
Secondary Bladder Cancer
19%
Deep Ensemble
19%
Digestive System Cancer
19%
Robot-assisted Radical Nephrectomy
19%
Ensemble Machine Learning
19%
Inferior Vena Cava Thrombectomy
19%
Critical Risk Factors
19%
Intracorporeal Ileal Conduit
19%
Kidney Donor Profile Index
19%
Kidney Donor Risk Index
19%
Resistance to Immunotherapy
19%
Urethral Suspension
19%
Intraoperative Navigation
19%
Selective Clamping
19%
Laparoscopic Retroperitoneal Lymph Node Dissection
19%
3D Printer
19%
Transplantation Surgery
19%
Printer Model
19%
Partial Nephrectomy
19%
Outcome Patterns
19%
Tailor-made
19%
Computed Tomography
19%
Alanine-serine-cysteine Transporter
19%
Bladder Eversion
19%
Renin-angiotensin-aldosterone System
19%
Legionella Pneumonia
19%
Sacrocolpopexy
19%
Nomogram
19%
Hugo RAS
15%
RAS System
15%
Printing System
14%
Three-dimensional Printing
14%
Bladder Neck Reconstruction
14%
Urethral Recurrence
14%
Postoperative Day
12%
Systemic Symptoms
12%
Postoperative Pneumonia
12%
Antimicrobial Therapy
12%
Geriatric 8
12%
Digestive System
9%
Continence Recovery
9%
Pelvic Cavity
9%
Rectus Fascia
9%
Cystopexy
9%
Burch Colposuspension
9%
Simple Machine
8%
Nerve Sparing
8%
Epithelial Metaplasia
7%
